Inicio > Oncología > Metastasis sincrónica de carcinoma de células renales en uréter, pared costal y pulmón. Sunitinib y cirugía > Página 3

Metastasis sincrónica de carcinoma de células renales en uréter, pared costal y pulmón. Sunitinib y cirugía

anatomia-patologica-tumoracion
Anatomia Patológica. Tumoración

Figura 3. Carcinoma de células renales metastásico a bajo aumento (HE x 25) del uréter mostrando sólidos nidos y cordones de células epiteliales, con citoplasma claro, núcleos irregulares y nucleolos pequeños. Vista a gran aumento (HE x 40) con las características clásicas de carcinoma renal de células claras.

REFERENCIAS BIBLIOGRÁFICAS

[1]        Jemal A, Siegel R, Ward E et al. Cancer statistics, 2008. CA: a cancer journal for clinicians. 2008; 58: 71-96.

[2]        Mekhail TM, Abou-Jawde RM, Boumerhi G et al. Validation and extension of the Memorial Sloan-Kettering prognostic factors model for survival in patients with previously untreated metastatic renal cell carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005; 23: 832-41.

[3]        Motzer RJ, Hutson TE, Tomczak P et al. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. N Engl J Med. 2007; 356: 115-24.

[4]        Perdona S, Autorino R, Gallo L et al. Renal cell carcinoma with solitary toe metastasis. International journal of urology : official journal of the Japanese Urological Association. 2005; 12: 401-4.

[5]        Leoard AM, Lefevre A, and Lagrange W. Ureteral stump metastasis from renal adenocarcinoma: case report and literature review. Acta Urol Belg. 1996; 64: 23-5.

[6]        Mayer WA, Resnick MJ, Canter D et al. Synchronous metastatic renal cell carcinoma to the genitourinary tract: two rare case reports and a review of the literature. The Canadian journal of urology. 2009; 16: 4611-4.

[7]        Flanigan RC, Mickisch G, Sylvester R, Tangen C, Van Poppel H, Crawford ED. Cytoreductive nephrectomy in patients with metastatic renal cancer: a combined analysis. J Urol. 2004; 171: 1071-6.

[8]        Jocham D, Richter A, Hoffmann L et al. Adjuvant autologous renal tumour cell vaccine and risk of tumour progression in patients with renal-cell carcinoma after radical nephrectomy: phase III, randomised controlled trial. Lancet. 2004; 363: 594-9.

[9]        Uzzo RG, Rayman P, Kolenko V et al. Mechanisms of apoptosis in T cells from patients with renal cell carcinoma. Clin Cancer Res. 1999; 5: 1219-29.

[10]      van der Poel HG, Roukema JA, Horenblas S, van Geel AN, Debruyne FM. Metastasectomy in renal cell carcinoma: A multicenter retrospective analysis. Eur Urol. 1999; 35: 197-203.